Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
Amazon sues AI startup over browser’s automated shopping and buying feature
5/11/2025
The Guardian has only ever published 15 zero-star reviews. Here they all are
5/11/2025
WTA Finals tennis : Anisimova sends Swiatek out ; Rybakina beats Alexandrova – as it happened
5/11/2025
Mamdani refused to compromise on his values – and was rewarded for it | Moustafa Bayoumi
5/11/2025
Alex vs ARod : the baseball legend turned ‘recovering narcissist’ tells all
5/11/2025
The Makropulos Case review : Ausrine Stundyte is magnetic in exhilarating – and funny – Janáček staging
5/11/2025